Download Unicorn Signals App

Powered By EquityPandit

Tag : US Patent and Trademark Appeal Board (PTAB)


US FDA Approves Biocon’s Insulin Glargine Injection Semglee

Amrita Chakravorty
The US Food and Drug Administration has approved Biocon Biologics India Ltd’s insulin glargine injection Semglee for controlling high blood sugar in adults with diabetes, the company said. Semglee,...